{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:15:08Z","timestamp":1778253308233,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rmr.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:28:41Z","timestamp":1774528121000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fragilit\u00e9 et pneumopathies interstitielles fibrosantes\u00a0: quels enjeux cliniques\u00a0?"],"prefix":"10.1016","volume":"43","author":[{"given":"C.","family":"Menigoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Huet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dirou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2026.02.001_bib0240","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.rmr.2026.02.001_bib0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.arr.2015.04.001","article-title":"Modifications to the frailty phenotype criteria: systematic review of the current literature and investigation of 262\u00a0frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe","volume":"21","author":"Theou","year":"2015","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.rmr.2026.02.001_bib0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62\u00a0countries across the world: a systematic review and meta-analysis of population-level studies","volume":"50","author":"O\u2019Caoimh","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.rmr.2026.02.001_bib0255","doi-asserted-by":"crossref","first-page":"e043494","DOI":"10.1136\/bmjopen-2020-043494","article-title":"Prevalence and risk factors of frailty among people in rural areas: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmr.2026.02.001_bib0260","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.arr.2012.03.001","article-title":"Association of frailty with survival: a systematic literature review","volume":"12","author":"Shamliyan","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.rmr.2026.02.001_bib0265","doi-asserted-by":"crossref","first-page":"e008462","DOI":"10.1136\/bmjopen-2015-008462","article-title":"Impact of physical frailty on disability in community-dwelling older adults: a prospective cohort study","volume":"5","author":"Makizako","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmr.2026.02.001_bib0270","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/jnr.0000000000000299","article-title":"Frail phenotype and disability prediction in community-dwelling older people: a systematic review and meta-analysis of prospective cohort studies","volume":"27","author":"Chang","year":"2019","journal-title":"J Nurs Res"},{"key":"10.1016\/j.rmr.2026.02.001_bib0275","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.ijnurstu.2015.04.005","article-title":"Frail phenotype and mortality prediction: a systematic review and meta-analysis of prospective cohort studies","volume":"52","author":"Chang","year":"2015","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.rmr.2026.02.001_bib0280","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","article-title":"Physical frailty: ICFSR international clinical practice guidelines for identification and management","volume":"23","author":"Dent","year":"2019","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.rmr.2026.02.001_bib0285","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/bjsports-2014-094306","article-title":"Even a low dose of moderate-to-vigorous physical activity reduces mortality by 22\u00a0% in adults aged \u2265\u00a060\u00a0years: a systematic review and meta-analysis","volume":"49","author":"Hupin","year":"2015","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2019.04.007","article-title":"Multicomponent exercise and the hallmarks of frailty: considerations on cognitive impairment and acute hospitalization","volume":"122","author":"Cadore","year":"2019","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.rmr.2026.02.001_bib0295","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/jcm10081630","article-title":"Benefits of resistance training in early and late stages of frailty and sarcopenia: a systematic review and meta-analysis of randomized controlled studies","volume":"10","author":"Talar","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.physio.2021.05.008","article-title":"Pilates improves physical performance and decreases risk of falls in older adults: a systematic review and meta-analysis","volume":"112","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2021","journal-title":"Physiotherapy"},{"key":"10.1016\/j.rmr.2026.02.001_bib0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12877-015-0155-4","article-title":"Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials","volume":"15","author":"de Labra","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rmr.2026.02.001_bib0310","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","article-title":"Management of frailty: opportunities, challenges, and future directions","volume":"394","author":"Dent","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2026.02.001_bib0315","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"Sci World J"},{"key":"10.1016\/j.rmr.2026.02.001_bib0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2010.08.008","article-title":"Frailty defined by deficit accumulation and geriatric medicine defined by frailty","volume":"27","author":"Rockwood","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0325","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.rmr.2026.02.001_bib0330","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40520-020-01478-3","article-title":"Operationalization of a frailty index among older adults in the InCHIANTI study: predictive ability for all-cause and cardiovascular disease mortality","volume":"32","author":"Hoogendijk","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.rmr.2026.02.001_bib0335","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jamda.2015.04.007","article-title":"Components of the frailty phenotype in relation to the frailty index: results from the Toulouse Frailty Platform","volume":"16","author":"Hoogendijk","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.rmr.2026.02.001_bib0340","doi-asserted-by":"crossref","first-page":"102243","DOI":"10.1016\/j.arr.2024.102243","article-title":"The measurement properties and feasibility of FRAIL scale in older adults: a systematic review and meta-analysis","volume":"95","author":"Ng","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.rmr.2026.02.001_bib0345","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jamda.2018.04.006","article-title":"Frailty defined by FRAIL scale as a predictor of mortality: a systematic review and meta-analysis","volume":"19","author":"Kojima","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.rmr.2026.02.001_bib0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5770\/cgj.19.196","article-title":"Clinical Frailty Scale in an acute medicine unit: a simple tool that predicts length of stay","volume":"19","author":"Juma","year":"2016","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.rmr.2026.02.001_bib0355","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12877-019-1315-8","article-title":"Validation of the clinical frailty score in French language","volume":"19","author":"Abraham","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rmr.2026.02.001_bib0360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12877-019-1042-1","article-title":"FRAILTOOLS study protocol","volume":"19","author":"Checa-L\u00f3pez","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rmr.2026.02.001_bib0365","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/jcsm.12990","article-title":"The ability of eight frailty instruments to identify adverse outcomes across different settings","volume":"13","author":"Oviedo-Briones","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.rmr.2026.02.001_bib0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1479972316679664","article-title":"Sarcopenia and frailty in chronic respiratory disease","volume":"14","author":"Bone","year":"2017","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.rmr.2026.02.001_bib0375","doi-asserted-by":"crossref","DOI":"10.1177\/14799731231196582","article-title":"Prevalence and assessment of frailty in interstitial lung disease","volume":"20","author":"Weber","year":"2023","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.rmr.2026.02.001_bib0380","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/resp.14066","article-title":"Prevalence and prognostic impact of physical frailty in interstitial lung disease","volume":"26","author":"Farooqi","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2026.02.001_bib0385","doi-asserted-by":"crossref","first-page":"1900647","DOI":"10.1183\/13993003.00647-2019","article-title":"Functional ageing in fibrotic interstitial lung disease","volume":"55","author":"Guler","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2026.02.001_bib0390","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.chest.2024.02.043","article-title":"The Clinical Frailty Scale for risk stratification in fibrotic interstitial lung disease","volume":"166","author":"Guler","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2026.02.001_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.012","article-title":"Severity and features of frailty in systemic sclerosis-associated interstitial lung disease","volume":"129","author":"Guler","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0400","doi-asserted-by":"crossref","DOI":"10.1177\/14799731241240786","article-title":"Clinical implications of frailty in hospitalized patients with acute exacerbation of interstitial lung disease","volume":"21","author":"Van Hollebeke","year":"2024","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.rmr.2026.02.001_bib0405","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rmed.2019.01.008","article-title":"Frailty and geriatric conditions in idiopathic pulmonary fibrosis","volume":"148","author":"Sheth","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0410","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12931-024-02705-5","article-title":"Association of musculoskeletal involvement with lung function and mortality in IPF","volume":"25","author":"Sridhar","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2026.02.001_bib0415","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2026.02.001_bib0420","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0425","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12890-021-01783-1","article-title":"Efficacy of antifibrotic drugs in progressive pulmonary fibrosis","volume":"21","author":"Finnerty","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.rmr.2026.02.001_bib0430","doi-asserted-by":"crossref","first-page":"2300752","DOI":"10.1183\/13993003.00752-2023","article-title":"Effects of nintedanib on symptoms in progressive pulmonary fibrosis","volume":"63","author":"Wijsenbeek","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2026.02.001_bib0435","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.chest.2021.06.049","article-title":"Impact of antifibrotic therapy on mortality in IPF","volume":"160","author":"Petnak","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2026.02.001_bib0440","doi-asserted-by":"crossref","first-page":"e0251636","DOI":"10.1371\/journal.pone.0251636","article-title":"Safety of nintedanib for interstitial lung disease","volume":"16","author":"Chen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2026.02.001_bib0445","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40001-021-00601-y","article-title":"Effects and safety of pirfenidone in IPF","volume":"26","author":"Zang","year":"2021","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.rmr.2026.02.001_bib0450","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12931-021-01695-y","article-title":"Efficacy and safety of nintedanib in elderly patients","volume":"22","author":"Glaspole","year":"2021","journal-title":"Respir Res"},{"issue":"Suppl. 3","key":"10.1016\/j.rmr.2026.02.001_bib0455","first-page":"A153","article-title":"Clinical frailty score and antifibrotic discontinuation in IPF","volume":"72","author":"Davies","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2026.02.001_bib0460","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/TP.0000000000002901","article-title":"Frailty as predictor of mortality in lung transplantation candidates","volume":"104","author":"Montgomery","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2026.02.001_bib0465","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/resp.12944","article-title":"Frailty and dyspnoea severity in fibrotic interstitial lung disease","volume":"22","author":"Milne","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2026.02.001_bib0470","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jos.2023.11.012","article-title":"Frailty in rheumatoid arthritis-associated ILD","volume":"29","author":"Ohashi","year":"2024","journal-title":"J Orthop Sci"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842526000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842526000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:58:32Z","timestamp":1778252312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842526000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0761842526000045"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2026.02.001","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fragilit\u00e9 et pneumopathies interstitielles fibrosantes\u00a0: quels enjeux cliniques\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SPLF. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}